Pharmaceutical surveillance with rapid spectroscopic screening technologies

American Pharmaceutical Review

Volumn 13, Issue 1, 2010, Pages 58-62

  Kauffman, John F ^a   Gryniewicz Ruzicka, Connie M ^a   Arzhantsev, Sergey ^a   Dunn, Jamie D ^a   Spencer, John A ^a   Wolfgang, Steven ^a   Li, Xiang ^a   Pelster, Lindsey N ^a   Westenberger, Benjamin J ^a   Buhse, Lucinda F ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CALIBRATION; CHEMOMETRICS; FEASIBILITY STUDY; ION MOBILITY SPECTROMETRY; NEAR INFRARED SPECTROSCOPY; RAMAN SPECTROMETRY; SCREENING TEST; SPECTROSCOPY; X RAY FLUORESCENCE;

EID: 77649202541     PISSN: 10998012     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. (a) Deborah M. Autor, "Globalization: Challenges and Recent Case Studies" DCAT Week, New York, March 18, 2009 (b) "Are your Drugs Safe?" U. S. News and World Report, October 5, 2007
2. Randall Lutter, "Addressing Challenges of Economically-Motivated Adulteration" Public Meeting on Economically Motivated Adulteration, College Park, MD, May 1, 2009 http://www.fda.gov/NewsEvents/ MeetingsConferencesWorkshops/ucm163619.htm
3. Allan Coukell, "Protecting Consumers from Adulterated Drugs" Public Meeting on Economically Motivated Adulteration, College Park, MD, May 1, 2009 http://www.fda.gov/NewsEvents/MeetingsConferencesWorkshops/ucm163619.htm
4. "Contaminant found in Heparin" Washington Post, March 6, 2008
5. U.S. Department of Health and Human Services, Food and Drug Administration, Guidance for Industry, "Testing of Glycerin for Diethylene Glycol" May 2007 http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/ucm070347.pdf
6. "Supplements for Athletes Draw Alert from FDA" New York Times, July 28, 2009
7. U.S. Department of Health and Human Services, Food and Drug Administration, "Warning on Body Building Products Marketed as Containing Steroids or Steroid-like Substances" July 28, 2009 http://www.fda.gov/ forconsumers/consumerupdates/ucm173739.htm
8. John C. Reepmeyer, Jeffrey T. Woodruff, and D. André d'Avignon "Structure elucidation of a novel analogue of sildenafil detected as an adulterant in an herbal dietary supplement", Journal of Pharmaceutical and Biomedical Analysis (2007) 43, 1615-1621
9. Connie M. Gryniewicz, John C. Reepmeyer, John F. Kauffman and Lucinda F. Buhse, "Detection of Undeclared Erectile Dysfunction Drugs and Analogues in Dietary Supplements by Ion Mobility Spectrometry", Journal of Pharmaceutical and Biomedical Analysis (2009) 49, 601-606
10. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) , Guidelines for Industry Q2A, Text on Validation of Analytical Procedures, 1995
11. Connie M. Gryniewicz, John A. Spencer, Michael Hankins and John F. Kauffman, "Spectroscopic methods for rapid determination of diethylene glycol in glycerin" American Pharmaceutical Review (2007), 10, 24-30 (Issue 7, Nov/Dec)
12. Lloyd A. Currie, "Limits for Qualitative Detection and Quantitative Determination" Analytical Chemistry (1968) 40, 586-593 http://www. cstl.nist.gov/div837/Division/about/Currie-1968.pdf , see also http://nvl. nist.gov/pub/nistpubs/sp958-lide/164-166.pdf
13. "Science from Art" Chemical and Engineering News, October 19, 2009
14. Dennis J. Kalnicky and Raj Singhvi, "Field portable XRF analysis of environmental samples" Journal of Hazardous Materials (2001) 83, 93-122